Sonova stock edges higher as Swiss hearing group trades near yearly highs
Published on 09/02/2026 at 08:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sonova stock (ISIN CH0012549785) was quoted at 232.80 CHF on the SIX Swiss Exchange around midday on September 1, 2026, up 0.3 percent from an opening level of 233.00 CHF according to data reported by finanzen.ch.
Stock supported by Swiss blue chip demand
Market data compiled by finanzen.ch on September 1, 2026 shows Sonova among the stronger names in the Swiss Large and Mid Cap Index SLI, with the share up 0.78 percent at 234.00 CHF while the broader index ended weaker that day.
Intraday quote information from a Swiss-focused trading overview cited Sonova at a bid of 232.00 CHF and an ask of 232.40 CHF on September 1, 2026, implying a narrow spread and indicating ongoing liquidity in the stock despite the softer overall Swiss market environment.
Recent financial performance and growth comparison
In its most recent reported financial period, Sonova highlighted continued growth in its hearing instruments and cochlear implants businesses, with revenue and profitability metrics that kept the company on track with its mid term growth ambitions. For investors, the key comparison remains how much faster Sonova can grow earnings versus the broader medtech sector, which has been expanding at high single digit rates in recent years.
Based on the latest available annual and interim figures cited by financial portals in 2025 and early 2026, Sonova reported revenue growth in the high single digit to low double digit percent range year on year, while maintaining an operating margin that underscores the pricing power of its premium hearing solutions. Historical figures from earlier fiscal years indicated that revenue in fiscal year 2023 had been materially lower, underlining the progress the company has made since then.
More Sonova stock coverage and data
All current articles, charts and regulatory releases on Sonova stock can be found in the dedicated ISIN topic overview.
Hearing aids as a core product line
One of Sonova's core product lines is advanced hearing aids, which combine miniaturized hardware with digital signal processing to improve speech understanding in noisy environments. These devices are sold under several brands through audiologists and hearing care professionals worldwide, making the segment a key contributor to group revenue and earnings.
Sonova stock on the SIX Swiss Exchange
With Sonova stock trading around 232.80 CHF as of September 1, 2026 on the SIX Swiss Exchange, near intraday levels of 234.00 CHF reported in the Swiss SLI overview, the share price remains close to its recent highs and reflects investors' confidence in the company's ability to grow profitably in the global hearing care market.
Sonova stock at a glance
- Company: Sonova Holding AG
- ISIN: CH0012549785
- Ticker: SOON
- Trading venue: SIX Swiss Exchange
- Price (as of September 1, 2026): 232.80 CHF
- Market capitalization: not specified (as of recent data)
- Sector / Industry: Healthcare / Medical Devices (Hearing Care)
- Index membership: SLI
